Researchers express alarm over integrity of key genetic databases

Many fear the Trump administration could damage NIH tools — by accident if not by design.

February 10, 2025 Check out STAT+

Sponsored By

Adobe STAT+ | Amid shakeup in U.S. science, researchers express alarm over integrity of key genetic databases Many fear that, in the process of making cuts, the Trump administration could harm GenBank and the Sequence Read Archive by accident if not design. By Helen Branswell 22 states sue to block Trump administration cuts to NIH research payments States sue to block NIH research cuts, arguing Trump administration move creates immediate harm to U.S. research institutions By Jonathan Wosen and Angus Chen STAT+ | Here's how big a hit some universities may take if NIH slashes support for indirect research costs Documents analyzed by STAT show that big losers under the NIH's cuts to "indirect costs" include Stanford, Vanderbilt, Cornell, the UT system. By Angus Chen and Jonathan Wosen Photo illustration: Christine Kao/STAT; Photo: Adobe STAT+ | Two biotechs say they're using AI to conjure drugs from scratch. Their documents suggest otherwise  AI drug discovery claims face scrutiny. Are Absci and Generate Biomedicines truly innovating, or is it biotech hype? Can AI build a drug from scratch? By Brittany Trang Opinion: The FDA's misguided thinking on antibiotics The FDA and industry focus on killing bugs in test tubes. That's not the right way to think about antibiotics. By Diana M. Zuckerman and John H. Powers III STAT+ | Mass General Brigham announces largest layoff in its history amid ongoing restructuring Mass General Brigham is grappling with anticipated financial shortfalls and ongoing operational challenges at its 12 hospitals. By Jessica Bartlett — Boston Globe Adobe STAT+ | Opinion: The life sciences industry needs a new approach As life science consultants, we've noticed many of the challenges clients face in the market originate in how they perceive their role in patients' lives. By Noël Theodosiou and Yogi Hendlin STAT+ | FDA cites Indian ingredients supplier for deleting records The FDA warning highlights ongoing anxiety over quality control among pharmaceutical manufacturers in India. By Ed Silverman

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser